Récidive d'appendicite sur moignon appendiculaire (Une réalité à ne pas méconnaître)

ST QUENTIN EN YVELINES-BU (782972101) / SudocPARIS-BIUM (751062103) / SudocSudocFranceF

L'ATAXIE CEREBELLEUSE AIGUE VIRALE DE L'ENFANT (ELABORATION D'UN OUTIL PEDAGOGIQUE MULTIMEDIA)

ST QUENTIN EN YVELINES-BU (782972101) / SudocPARIS-BIUM (751062103) / SudocSudocFranceF

Atrésie de l'œsophage (évolution à moyen et long terme, morbidité et mortalité)

PARIS7-Xavier Bichat (751182101) / SudocPARIS-BIUM (751062103) / SudocSudocFranceF

Discographies : Mireille et Yves Montand

SONORITES vous propose en ce numéro la discographie (complète) de MIREILLE, et le tout début de celle d'Yves MONTAND. La première, mise en ordre par Gérard Roig, et complétée, à l'ère du microsillon, par Raoul Bellaïche, ne pose guère de problèmes. On notera toutefois que Mireille a confié au disque, à plusieurs reprises, des interprétations qui n'ont jamais été publiées. Pour ce qui est des enregistrements d'Yves Montand en 78 tours, la recension en était à la fois simple et désespérée. Simp..

Discographies : Mireille et Yves Montand

SONORITES vous propose en ce numéro la discographie (complète) de MIREILLE, et le tout début de celle d'Yves MONTAND. La première, mise en ordre par Gérard Roig, et complétée, à l'ère du microsillon, par Raoul Bellaïche, ne pose guère de problèmes. On notera toutefois que Mireille a confié au disque, à plusieurs reprises, des interprétations qui n'ont jamais été publiées. Pour ce qui est des enregistrements d'Yves Montand en 78 tours, la recension en était à la fois simple et désespérée. Simp..

Whole Goat Milk-Based Formula versus Whey-Based Cow Milk Formula: What Formula Do Infants Enjoy More?—A Feasibility, Double-Blind, Randomized Controlled Trial

(1) Background: While goat milk formula (GMF) is an alternative to cow milk formula (CMF), infants’ preferences for one over the other have not been formally assessed. Specifically, our aim in this study was to determine whether infants experience fewer feeding behavior problems with whole milk-based GMF than with conventional whey-based CMF. (2) Methods: This was a multicenter, double-blind, randomized controlled trial with two-arm parallel assignment conducted in six pediatricians’ offices in or near Paris, France, between June 2018 and 31 December 2021. Overall, 64 healthy infants (≤4 months old), predominantly formula-fed, were randomly assigned to either the whole milk-based GMF (n = 33) or whey-based CMF (n = 31) arm. Parents completed the Baby Eating Behavior Questionnaire (BEBQ) and the modified QUALIN questionnaire to evaluate infant feeding behavior and quality of life (psychomotor and socioemotional development), respectively, at inclusion (1 to 5 days before milk delivery) and the final visit (day 28 ± 3 after milk delivery). Informed consent was obtained for all recruited patients, and an ethical committee approved the study. (3) Results: Changes in BEBQ Enjoyment of Food and Slowness in Eating subscale scores from inclusion to final visit did not differ between arms. However, there were significant improvements in subscale scores for Food Responsiveness (GMF: 0.15 ± 1; CMF: −0.48 ± 0.81; p = 0.010) and General Appetite (GMF: 0.26 ± 1.2; CMF: −0.48 ± 0.88; p = 0.012), and modified QUALIN (GMF: 4.6 ± 9.4; CMF: −0.40 ± 7.6; p = 0.03) scores in favor of the GMF group. (4) Conclusions: In this double-blind, randomized controlled trial, GMF-fed infants exhibited a greater general appetite than CMF-fed infants, possibly due to differences in the composition of these formulas (i.e., protein and lipid profiles). In addition, GMF-fed infants enjoyed a better quality of life. There was no difference in food enjoyment between groups. These findings suggest that whole-milk-based GMF could be an attractive alternative to whey-based CMF. Clinical trial registration: NCT03488758 (clinicaltrials.gov)

Priority target conditions for algorithms for monitoring children's growth: Interdisciplinary consensus

<div><p>Background</p><p>Growth monitoring of apparently healthy children aims at early detection of serious conditions through the use of both clinical expertise and algorithms that define abnormal growth. Optimization of growth monitoring requires standardization of the definition of abnormal growth, and the selection of the priority target conditions is a prerequisite of such standardization.</p><p>Objective</p><p>To obtain a consensus about the priority target conditions for algorithms monitoring children's growth.</p><p>Methods</p><p>We applied a formal consensus method with a modified version of the RAND/UCLA method, based on three phases (preparatory, literature review, and rating), with the participation of expert advisory groups from the relevant professional medical societies (ranging from primary care providers to hospital subspecialists) as well as parent associations. We asked experts in the pilot (n = 11), reading (n = 8) and rating (n = 60) groups to complete the list of diagnostic classification of the <i>European Society for Paediatric Endocrinology</i> and then to select the conditions meeting the four predefined criteria of an ideal type of priority target condition.</p><p>Results</p><p>Strong agreement was obtained for the 8 conditions selected by the experts among the 133 possible: celiac disease, Crohn disease, craniopharyngioma, juvenile nephronophthisis, Turner syndrome, growth hormone deficiency with pituitary stalk interruption syndrome, infantile cystinosis, and hypothalamic-optochiasmatic astrocytoma (in decreasing order of agreement).</p><p>Conclusion</p><p>This national consensus can be used to evaluate the algorithms currently suggested for growth monitoring. The method used for this national consensus could be re-used to obtain an international consensus.</p></div

Different phases of the formal consensus process (modified version of the RAND/UCLA method).

<p>Different phases of the formal consensus process (modified version of the RAND/UCLA method).</p

Results of the rating phase of the target conditions judged to be priorities for growth monitoring (n = 36 experts of 68).

<p>Results of the rating phase of the target conditions judged to be priorities for growth monitoring (n = 36 experts of 68).</p